Popular Articles From: Blackbaud Welcomes Pete Kight to Board of Directors to Schwab Announces Zero Capital Gains Distributions for Schwab ETFsTM for Fifth Consecutive Year


Blackbaud, Inc. (NASDAQ: BLKB ), a leading global provider of software and services for the nonprofit, charitable giving and education communities, today announced that Peter (Pete) Kight, founder, and former chairman and CEO of CheckFree, has been elected to its Board of Directors .
Sign-up for Blackbaud Welcomes Pete Kight to Board of Directors investment picks
Formulated to Help Alleviate Symptoms Associated with Fibrocystic Breast Condition for the Estimated 50 Percent of Women Aged 15 to 49 Who Suffer from Monthly Breast Discomfort MENLO PARK, Calif.
Sign-up for Introducing Violet™ Iodine, New Once-Daily, Non-Prescription Pill For Relief Of Premenstrual Breast Discomfort* investment picks
New e-Book, Hosted by TeleTech Founder and CEO Ken Tuchman, Brings Together Business, Design and Science Experts in a Conversation about Our Connected Future DENVER , Dec.
Sign-up for Introducing The Technology of Us, a Provocative Discussion About the New Relationship Between Technology and Humanity investment picks
Company Nominates New Director PHILADELPHIA , Dec.
Sign-up for Aramark Announces Eric Foss to Become Chairman of the Board; Joseph Neubauer to Step Down at 2015 Annual Meeting After 30 Years as Chairman investment picks
2014/12/2
Bank of America Chief Executive Officer Brian Moynihan will present at the Goldman Sachs U.S. Financial Services Conference in New York on Tuesday, December 9, at 8:40 a.m. Eastern Time.
Sign-up for Bank of America to Participate in the Goldman Sachs U.S. Financial Services Conference on December 9 investment picks
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, today announced that the European Medicines Agency (EMA) has validated and initiated its review of the company’s marketing authorization application (MAA) for Natpar ® (parathyroid hormone (rDNA)) for the treatment of Hypoparathyroidism, a rare endocrine disorder characterized by insufficient levels of parathyroid hormone (PTH). If approved, Natpar would be the first and only PTH replacement therapy in Europe for patients with Hypoparathyroidism.
Sign-up for European Medicines Agency Validates Marketing Authorization Application for Natpar® (parathyroid hormone (rDNA)) in Hypoparathyroidism investment picks
Helps Consumers Maximize Credit Card Rewards, Deepens Mobile Expertise & Establishes Ongoing Customer Relationship With Audience NEW YORK , Dec.
Sign-up for Bankrate, Inc. Announces Acquisition of Wallaby Financial investment picks
2014/12/1
By Andria Cheng, MarketWatch NEW YORK (MarketWatch) -- Black Friday may have been a loser this year.
Sign-up for Here are Black Friday's winners and losers investment picks
2014/12/1
RH (Restoration Hardware Holdings, Inc.—NYSE: RH) announced today the opening, on November 21, of RH Atlanta, The Gallery at the Estate in Buckhead at 3030 Peachtree Road NW.
Sign-up for Restoration Hardware Announces the Opening of RH Atlanta, the Gallery at the Estate in Buckhead investment picks
Molina Healthcare, Inc. (NYSE:MOH) announced that, effective today, its wholly owned subsidiary Molina Healthcare of Florida, Inc. has closed on its acquisition of certain assets relating to the Florida Medicaid business of First Coast Advantage, LLC.
Sign-up for Molina Healthcare of Florida Completes Acquisition of Florida Medicaid Assets from First Coast Advantage investment picks
Service between Houston and six destinations in three countries to begin in October 2015, subject to government approval: Cancun, Mexico City, Puerto Vallarta, and San Jose del Cabo/Los Cabos, Mexico; San Jose, Costa Rica; and Belize City, Belize DALLAS , Dec.
Sign-up for Southwest Airlines Files Applications To Serve Four Destinations In Mexico Plus Belize And Costa Rica From Houston (Hobby) investment picks
2014/12/8
By Sara Sjolin, MarketWatch Battered European shares may offer a good value play LONDON (MarketWatch) -- With the S&P 500 index and Dow Jones Industrial Average close to record highs, it could be a perfect time to bet big on Europe, HSBC said in a note on Monday.
Sign-up for UPDATE: Forget U.S. stocks, European shares are your best bet in 2015 investment picks
2014/12/8
NEW YORK , Dec.
Sign-up for KPS Capital Partners Portfolio Company, Expera Specialty Solutions Acquires Old Town Fuel & Fiber investment picks
Intrawest Resorts Holdings, Inc. ( NYSE:SNOW ), a leading North American mountain resort and adventure company, today announced the promotion of Travis Mayer to the position of Executive Vice President, Chief Financial Officer and Treasurer, effective immediately.
Sign-up for Intrawest Announces Appointment of New Chief Financial Officer investment picks
American Eagle Outfitters, Inc. (NYSE:AEO) today announced that total net revenue for the nine-week period ended January 3, 2015 increased 1% to $893 million, compared to $882 million for the nine-week period ended January 4, 2014.
Sign-up for American Eagle Outfitters Announces Holiday Sales, Raises Fourth Quarter EPS Guidance Range investment picks
Peak Season Preparations Helped Retailers to Take Advantage of Holiday Season Demand UPS Survey: Online Shoppers Expect Easy Returns Easy Holiday Returns via The UPS Store, UPS Access Point Locations or Driver Pickup ATLANTA, Dec.
Sign-up for UPS Wraps Up The Holidays With Returns investment picks
2015/1/7
Oil driller Helmerich & Payne Inc. shares (HP) fell 7.6% Wednesday to lead S&P 500 decliners, after the company told investors that low oil prices are having an impact on the U.S. land drilling market.
Sign-up for Helmerich & Payne shares fall as company says low oil price is hurting investment picks
Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today reported that it has completed enrollment in its Phase 2 dose optimization clinical trial for GEN-003 for the treatment of genital herpes.
Sign-up for Genocea Completes Enrollment Early in Phase 2 Dose Optimization Trial of GEN-003 for Treatment of Genital Herpes investment picks
2015/1/6
By Joseph Checkler A group of well-known financial institutions settled a lawsuit brought by former MF Global Holdings Ltd.
Sign-up for Group of Financial Institutions Settles MF Global Suit investment picks
Graco Inc. (NYSE:GGG) is saddened by the passing of David A.
Sign-up for Graco Saddened by Passing of David A. Koch, Former President, CEO, and Chairman investment picks
http://media.marketwire.com/attachments/201206/53265_TiVo_logo_2011_thumb.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1167279&ProfileId=051205&sourceType=1 LAS VEGAS, NV --
Sign-up for TiVo Demonstrating Impressive Product and Prototype Line at 2015 CES investment picks
2015/1/1
By Brett Arends, MarketWatch An energy glut threatens an auto industry success story Everybody loves Tesla Motors.
Sign-up for UPDATE: Can Tesla survive collapsing gas prices? investment picks
DOWNERS GROVE, Ill., Dec.
Sign-up for FTD Companies, Inc. to Present at 17th Annual ICR XChange Conference investment picks
2014/12/24
By Liz Hoffman Two takeover deals have been delayed amid slower-than-expected government approvals, the latest sign of the regulatory hurdles facing companies pursuing global mergers.
Sign-up for Cross Border Mergers Face Growing Scrutiny -- Update investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1164834&ProfileId=051205&sourceType=1 ROSELAND, NJ --
Sign-up for ADP(R) Offers Important Year-End Payroll and Tax Tips to Small Business Owners and Their Advisors investment picks
2015/1/9
By Claudia Assis, MarketWatch SAN FRANCISCO (MarketWatch) -- Wall Street is bracing for a 20% decline in energy companies' earnings in the fourth quarter -- and that's the good news.
Sign-up for Energy stocks brace for many quarters of earnings pressure investment picks
By Ron Winslow U.S. regulators Monday approved Bristol-Myers Squibb Co.'s Opdivo for advanced skin cancer, the latest drug to reach the market in the emerging field of cancer immunotherapy.
Sign-up for FDA approves Bristol-Myers's skin cancer treatment Opdivo investment picks
Charles Schwab Investment Management, Inc. (CSIM) reported today that there will be no capital gains distributions in 2014 by any of the 21 exchange-traded funds (ETFs) in the Schwab ETFs™ family.
Sign-up for Schwab Announces Zero Capital Gains Distributions for Schwab ETFsTM for Fifth Consecutive Year investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Popular Articles From: Blackbaud Welcomes Pete Kight to Board of Directors to Schwab Announces Zero Capital Gains Distributions for Schwab ETFsTM for Fifth Consecutive Year
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent